Source: SEC

NeuroLutions received $26.5M in Equity Funding

Read full article »

NeuroLutions's Competitors | NeuroLutions's News | NeuroLutions's Financials

Followers on Owler

2

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

CEO

Update CEO

CEO Approval Rating

- -/100

NeuroLutions is developing medical devices that use Brain Computer Interface technology to treat neurological disorder.